Ingredient-to-Brand Transition Board Adviser

The mandate

The producer supplies oils, proteins and functional ingredients to food manufacturers and now sees branded consumer products as a route to richer margins and proprietary demand. Pilot brands generated retailer interest, but their economics exclude working capital, returns, trade spend, consumer support and the risk that existing business customers view the move as competition. Manufacturing is optimised for bulk orders, not short runs and volatile assortment. The board needs to test whether brand ownership creates advantage or merely imports unfamiliar risk.

The adviser will challenge a right-to-win and capability map covering consumer problem, product evidence, brand trust, channel access, retail economics, marketing, demand planning, packaging, quality, inventory, returns, customer conflict, talent and capital. The review must distinguish branded ingredient, co-brand, private label, licensing, joint venture and wholly owned consumer routes. Higher gross margin cannot be treated as value before acquisition cost, service burden and failure inventory are included.

The cadence comprises fortnightly work with strategy and business leaders, monthly board-committee attendance and two customer and consumer evidence reviews. The adviser will interrogate pilots, retailer feedback and operating assumptions, making contrary evidence visible. Technical product claims, food regulation, quality, tax, legal and valuation conclusions remain with authorised specialists and management.

The adviser has no line authority and assumes no executive responsibility for brands, product, marketing, sales, manufacturing, quality or investment. The role cannot approve claims, contact customers without protocol, direct launches, negotiate retailers, select agencies, allocate capital or recommend a transaction. Executives own pilots; specialists own safety and claims; the board retains strategy and funding decisions. Advice is not a launch endorsement.

The appointment lasts nine months. Renewal requires a separate minuted branded-growth decision after current options close. Relationships with retailers, food brands, agencies, licensors, manufacturers, investors and existing ingredient customers must be disclosed. Relevant interests trigger recusal, and no agency, distribution, licensing, transaction or investment referral economics may be accepted.

Why the board wants this voice

Ingredient leaders value customer trust, marketers value consumer ownership and pilot sponsors emphasise gross margin, leaving capability and cannibalisation underchallenged. Retailers also express interest without carrying the producer’s inventory and reputation risk. An independent adviser can test strategic right and operating consequence without selling a launch, agency or distribution route.

What you will own

• Challenge the consumer problem, differentiated product evidence, brand trust, channel access and defensible right to win against real alternatives.
• Reconstruct economics across price, trade spend, acquisition, packaging, short runs, inventory, returns, support and failure.
• Map capability gaps in demand, marketing, retail, quality, fulfilment, data, customer care and portfolio management.
• Test ingredient customer conflict, cannibalisation, confidentiality, channel reaction and partnership alternatives.
• Compare brand, co-brand, private label, licensing, joint venture and no-entry options with investment gates.
• Maintain evidence, specialist dependencies, conflicts, recusals, dissent and board decision records.
• Deliver the strategic option map, capability sequence, pilot gates and residual customer-risk opinion.

Candidate qualifications

• Has advised food, ingredient or consumer boards on moving from business-to-business supply into branded demand through failed pilots and capability investment.
• Understands retail margin, trade spend, marketing, inventory, returns, quality, claims and channel economics.
• Can distinguish attractive gross margin from true consumer-business value and operating capability.
• Has challenged brand pilots while protecting existing manufacturer customers and confidential formulation relationships.
• Brings credible engagement with boards, food science, manufacturing, marketing, retailers, finance and quality.
• Is independent of agencies, distributors, licensors, transaction advisers, manufacturers and investment referrals.

Non-negotiables

• Can attend monthly Lisbon sessions and both customer and consumer evidence reviews despite remote work.
• Brings direct ingredient-to-consumer strategy; generic brand marketing or food manufacturing alone is insufficient.
• Will not approve claims, promise launches, approach customers privately or promote an agency or distributor.
• Will disclose ties to retailers, brands, agencies, licensors, investors, manufacturers and ingredient customers.

1. 49 words maximum. Which cost most often reverses a branded product’s apparent gross-margin advantage?
2. 49 words maximum. How would you test whether consumer entry damages an ingredient customer relationship?
3. 49 words maximum. What pilot evidence should precede investment in brand-scale capability?